World Journal of Laparoscopic Surgery

Register      Login

VOLUME 10 , ISSUE 3 ( September-December, 2017 ) > List of Articles

REVIEW ARTICLE

Laparoscopy in Cesarean Scar Pregnancy

R Meenakshi Menon

Citation Information : Menon RM. Laparoscopy in Cesarean Scar Pregnancy. World J Lap Surg 2017; 10 (3):135-138.

DOI: 10.5005/jp-journals-10033-1322

License: CC BY-NC 4.0

Published Online: 00-12-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: With the increase in rates of cesarean deliveries, complications in subsequent pregnancies like placenta accreta/percreta, uterine rupture, and cesarean scar ectopic pregnancy are on the rise. Cesarean scar pregnancy (CSP) accounts for about 2 to 4% of all ectopic pregnancies. Improvement in diagnostic techniques and advancement in transvaginal ultrasound and advent of minimal access surgery has contributed to early detection and timely management of CSP. Objective: This article aims to review different treatment modalities of CSP and hence to compare efficacy of laparoscopy with other management techniques. Materials and methods: Case series, retrospective cohort studies, and articles were reviewed which included studies from PubMed, MEDLINE, Cochrane library, and EMBASE. The main outcome was successful first-line treatment. Complications during treatment were listed as bleeding more than 1 L, blood transfusion, hysterectomy, and laparotomy. Results: Successful treatment and reduced complications were noted with laparoscopy as compared with medical management. Conclusion: Interventional than medical approach is preferred in management of CSP. Laparoscopic surgery helps in removal of ectopic tissue in cesarean scar with simultaneous repair of the defect under adequate visualization.


PDF Share
  1. Ash A, Smith A, Maxwell D. Caesarean scar pregnancy. BJOG 2007 Mar;114(3):253-263.
  2. Godin PA, Bassil S, Donnez J. An ectopic pregnancy developing in a previous caesarian section scar. Fertil Steril 1997 Feb;67(2):398-400.
  3. Maheux-Lacroix S, Li F, Bujold E, Nesbitt-Hawes E, Deans R, Abbott J. Cesarean scar pregnancies: a systematic review of treatment options. J Minim Invasive Gynecol 2017 Sep-Oct;24(6):915-925.
  4. Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ. First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol 2003 Mar;21(3): 220-227.
  5. Birch Petersen K, Hoffmann E, Rifbjerg Larsen C, Svarre Nielsen H. Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril 2016 Apr;105(4):958-967.
  6. Lee CL, Wang CJ, Chao A, Yen CF, Soong YK. Laparoscopic management of an ectopic pregnancy in a previous Caesarean section scar. Hum Reprod 1999 May;14(5):1234-1236.
  7. Shah NH, Paranjpe S, Shah VN. Scar ectopic pregnancy managed laparoscopically. JPGO 2017 Jul;4(7).
  8. Deans R, Abbott J. Hysteroscopic management of cesarean scar ectopic pregnancy. Fertil Steril 2010 Apr;93(6):1735-1740.
  9. Pan Y, Liu MB. The value of hysteroscopic management of cesarean scar pregnancy: a report of 44 cases. Taiwan J Obstet Gynecol 2017 Apr;56(2):139-142.
  10. Shu X, Lou S, Wang Z, Yao Y. Cesarean scar pregnancy treated by curettage and aspiration guided by laparoscopy. Ther Clin Risk Manag 2015 Aug;2015(11):1139-1141.
  11. Fuchs N, Manoucheri E, Verbaan M, Einarsson JI. Laparoscopic management of extrauterine pregnancy in caesarean section scar: description of a surgical technique and review of the literature. BJOG 2015 Jan;122(1):137-142.
  12. Hasegawa J, Ichizuka K, Matsuoka R, Otsuki K, Sekizawa A, Okai T. Limitations of conservative treatment for repeat cesarean scar pregnancy. Ultrasound Obstet Gynecol 2005 Mar;25(3):310-311.
  13. Ribeiro DM, Ribeiro GM, Cossi P, Santos TP, Freire M. Laparoscopy surgical treatment of caesarean scar ectopic pregnancy (CSEP): case report. Braz J Video-Sur 2013 Jul-Sep;6(3):124-129.
  14. Ades A, Parghi S. Laparoscopic resection of cesarean scar ectopic pregnancy. J Minim Invasive Gynecol 2017 May-Jun;24(4): 533-535.
  15. Api M, Boza A, Gorgen H, Api O. Should cesarean scar defect be treated laparoscopically? A case report and review of the literature. J Minim Invasive Gynecol 2015 Nov-Dec;22(7): 1145-1152.
  16. Mahgoub S, Gabriele V, Faller E, Langer B, Wattiez A, Lecointre L, Akladios C. Cesarean scar ectopic pregnancy. Laparoscopic resection and total scar dehiscence repair. A case report. J Minim Invasive Gynecol 2017;2017;S1553-4650(17)30098-30105.
  17. Albeladi B, Bourbao-Tournois C, Huten N. Short- and midterm results between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes 2013;2013:934653.
  18. Baker M. Surgical clinics of North America. Bar Met Surg 2011;91(6):1181-1201.
  19. Baltasar A, Serra C, Pérez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 2005 Sep;15(8):1124-1128.
  20. Biertho L, Steffen R, Branson R, Potoczna N, Ricklin T, Piec G, Horber FF. Management of failed adjustable gastric banding. Surgery 2005 Jan;137(1):33-41.
  21. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KGMM, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 2016 Jun;39:861-877.
  22. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg 2015 Oct;25:1822-1832.
  23. Li J, Lai D, Wu D. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 2016 Feb;26:429-442.
  24. Osland E, Yunus RM, Khan S, Memon B, Memon MA. Postoperative early major and minor complications in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review. Surg Laparosc Endosc Percutan Tech 2017 Feb;27:8-18.
  25. Perez RC. Current mapping of obesity. Nutr Hosp 2013 Sep;28(Suppl 5):21-31.
  26. Deitel M. The obesity epidemic. Obes Surg 2006 Apr;16(4): 377-378.
  27. Picot J, Jones J, Colquit JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. The clinical effectiveness and cost effectiveness of bariatric (weight loss) surgery for morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2009 Sep;13(41):1-190.
  28. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013 Apr;23(4):427-436.
  29. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003 Jan;289(2):187-193.
  30. Yanovski SZ. Overweight, obesity, and health risk: National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000 Apr;160(7):898-904.
  31. Franco JVA, Ruiz PA, Palermo M, Gagner M. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, roux-en-y gastric bypass and adjustable gastric banding. Obesity Surgery 2011;21(9):1458-1468.
  32. Karlsson J, Taft C, Rydén A, Sjöström L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes 2007 Aug;31(8):1248-1261.
  33. Wang, Y, Beydoun, MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6-28.
  34. Health Implications of Obesity. National Institute of Health consensus development conference statement. Ann Inter Med 1985 Dec;103(6 (Pt 2)):1073-1077.
  35. Frachetti, KJ, Goldfine, AB. Bariatric surgery for diabetes management. Curr Opin Endocrinol Diabetes Obes 2009 Apr;16(2):119-124.
  36. Fritscher LG, Canani S, Mottin CC, Fritscher CC, Berleze D, Chapman K, Chatkin JM. Bariatric surgery in the treatment of obstructive sleep apnea in morbidly obese patients. Respiration 2007;74(6):647-652.
  37. Shields M, Carroll MD, Ogden CL. Adult obesity prevalence in Canada and the United States. NCHS Data Brief 2011 Mar;(56):1-8.
  38. Sjostrom, L., Peltonen, M., Jacobson, P. et al, Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307: 56-65.
  39. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, La Monte MJ, Pendleton RC, Strong MB, Vinik R, Wanner NA, Hopkins PN, et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012 Sep;308(11):1122-1131.
  40. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009 Jul;361(5):445-454.
  41. Castillo OA, Vitagliano G, Díaz M, Sánchez-Salas R. Port-site metastasis after laparoscopic partial nephrectomy: case report and literature review. J Endourol 2007 Apr;21(4): 404-407.
  42. Muntener M, Nielsen ME, Romero FR, Schaeffer EM, Allaf ME, Brito FA, Pavlovich CP, Kavoussi LR, Jarrett TW. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur Urol 2007 Jun;51(6):1639-1644.
  43. Manabe D, Saika T, Ebara S, Uehara S, Nagai A, Fujita R, Irie S, Yamada D, Tsushima T, Nasu Y, et al.; Okayama Urological Research Group, Okayama, Japan. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007 Mar;69(3):457-461.
  44. Dhobada S, Patankar S, Gorde V. Port-site metastasis after laparoscopic radical nephrectomy for renal-cell carcinoma: case report. J Endourol 2006 Feb;20(2):119-122.
  45. Kobori Y, Shigehara K, Amano T, Takemae K. [Port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy: a case report]. Hinyokika Kiyo 2005 Feb;51(2):105-108.
  46. El-Tabey NA, Shoma AM. Port site metastases after robot assisted laparoscopic radical cystectomy. Urology 2005 Nov;66(5):1110.
  47. Porpiglia F, Fiori C, Bovio S, Destefanis P, Alì A, Terrone C, Fontana D, Scarpa RM, Tempia A, Terzolo M. Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery. J Endocrinol Invest 2004 Jul-Aug;27(7):654-658.
  48. Chueh S-CJ, Tsaia I-D, Laia M-K. Solitary port-site metastasis after laparoscopic bilateral nephroureterectomy for transitional cell carcinoma in a renal transplant recipient. Transplant Proc 2004 Nov;36(9):2697-2698.
  49. Naderi N, Nieuwenhuijzen JA, Bex A, Kooistra A, Horenblas S. Port site metastasis after laparoscopic nephro-ureterectomy for transitional cell carcinoma. Eur Urol 2004 Oct;46(4): 440-441.
  50. Iwamura M, Tsumura H, Matsuda D, Kurosaka S, Yoshida K, Baba S. Port site recurrence of renal cell carcinoma following retroperitoneoscopic radical nephrectomy with manual extraction without using entrapment sac or wound protector. J Urol 2004 Mar;171(3):1234-1235.
  51. Matsui Y, Ohara H, Ichioka K, Terada N, Yoshimura K, Terai A. Abdominal wall metastasis after retroperitoneoscopic assisted total nephroureterectomy for renal pelvic cancer. J Urol 2004 Feb;171(2 Pt 1):793.
  52. Saraiva P, Rodrigues H, Rodrigues P. Portsite recurrence after laparoscopic adrenalectomy for metastatic melanoma. Int Braz J Urol 2003 Nov-Dec;29(6):520-521.
  53. Chen YT, Yang SSD, Hsieh CH, Wang CC. Hand port-site metastasis of renal-cell carcinoma following hand-assisted laparoscopic radical nephrectomy: case report. J Endourol 2003 Nov;17(9):771-775.
  54. Wang PH, Yen MS, Juang CM, Chen YJ, Chao HT, Yuan CC. Intraperitoneal cancer spread after laparoscopic cystectomy for mature teratoma with malignant transformation. Eur J Gynaecol Oncol 2002;23(2):131-132.
  55. Castilho LN, Fugita OE, Mitre AI, Arap S. Port site tumor recurrences of renal cell carcinoma after videolaparoscopic radical nephrectomy. J Urol 2001 Feb;165(2):519.
  56. Landman J, Clayman RV. Re: port site tumor recurrences of renal cell carcinoma after videolaparoscopic radical nephrectomy (letter). J Urol 2001 Aug;166(2):629-630.
  57. Fentie DD, Barret PH, Taranger LA. Metastatic renal cell carcinoma after laparoscopic radical nephrectomy: long-term follow-up. J Endourol 2000 Jun;14(5):407-411.
  58. Otani M, Irie S, Tsuji Y. Port site metastasis after laparoscopic nephrectomy: unsuspected transitional cell carcinoma within a tuberculous atrophic kidney. J Urol 1999 Aug;162(2):486-487.
  59. Ahmed I, Shaikh NA, Kapadia CR. Track recurrence of renal pelvic transitional cell carcinoma after laparoscopic nephrectomy. Br J Urol 1998 Feb;81(2):319.
  60. Altieri V, D'Armiento M, Desio M, Ucciero G, Lotti T, Graziotti PP. Can laparoscopic lymphadenectomy disseminate bladder cancer? Acta Urol Ital 1998 Jan;12:231-233.
  61. Bangma C, Kirkels WJ, Chadha S, Schröder FH. Cutaneous metastasis following laparoscopic pelvic lymphadenectomy for prostatic carcinoma. J Urol 1995 May;153(5):1635-1636.
  62. Andersen JR, Steven K, Smith AD. Implantation metastasis after laparoscopic biopsy of bladder cancer. J Urol 1995 Mar;153(3 Pt 2):1047-1048.
  63. Maciel GA, Soares Junior (Jr), Alves Da Motta EL, Abi Haidar M, De Lima AR, Baracat EC. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil Steril 2004;81:355-60.
  64. Kumari AS, Haq A, Jayasundaram R, Abdel-Wareth LO, Al Haija SA, Alvarez M. Metformin monotherapy in lean women with polycystic ovary syndrome. R & Pro D. Biomed Online 2005;10:100-04.
  65. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. Effects of diet and metformin administration on sex hormone binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995;80:2057-62.
  66. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-74.
  67. Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:524-30.
  68. De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999;72:282-85.
  69. Yarali H, Yildiz B, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O, Koray Z. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: A prospective randomized trial. Hum Reprod 2002;17:289-94.
  70. Palomba S, Falbo A, Orio F (Jr), Manguso F, Russo T, Tolino A, Colao A, Dale B, Zullo F. A randomized controlled trial evaluating metformin pretreatment and coadministration in nonobese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian hyperstimulation plus timed intercourse or intrauterine insemination. Hum Reprod 2005 Jun 15 (Epub ahead of print).
  71. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 2001;75:505-09.
  72. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Impact of metformin therapy on ovarian stimulation and outcome in ‘coasted’ patients with polycystic ovary syndrome undergoing in vitro fertilization. Reprod Biomed Online 2002;5:112-16.
  73. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce firsttrimester spontaneous abortion: A pilot study. Fertil Steril 2001;75:46-52.
  74. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002;77:101-06.
  75. Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 1990;33:2933-42.
  76. Akhtar M, Njar VC, Wright JN. Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes. J Steroid Biochem Mol Biol 1993;44:375-87.
  77. Palter SF, Tavares AB, Hourvitz A, Veldhuis JD, Adashi EY. Are estrogens of import to primate/human ovarian folliculogenesis? Endocr Rev 2001;22:389-424.
  78. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-56.
  79. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-29.
  80. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992;13:641-69.
  81. Mitwally MF, Casper RF. Aromatase inhibitors for the treatment of infertility. Expert Opin Investig Drugs 2003;12:353-71.
  82. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005;192:381-86.
  83. Mitwally MFM, Casper RF. The use of aromatase inhibitor for induction of ovulation in cases of clomiphene citrate failure. Curr Opin Obstet Gynecol 2002;14:255-63.
  84. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305-09.
  85. Sammour A, Bijan MM, Tan SL, Tulandi T. Prospective randomised trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination (IUI). Fertil Steril 2001;76(Suppl 1):S110.
  86. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005;83:229-31.
  87. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002;78:280-85.
  88. Fatemi HM, Kalibianakis E, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Clomiphene citrate vs letrozole for ovarian stimulation: A pilot study. Reprod Biomed Online 2003;7:543-46.
  89. Hu Y, Cortvrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev 2002;61: 549-59.
  90. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal NR. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 1997;61:157-66.
  91. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003;18:1588-97.
  92. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002;77:776-80.
  93. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: A preliminary report. Hum Reprod 2004;19:2031-35.
  94. Newkirk KM, Chandler HL, Parent AE, et al. Ultraviolet radiation-induced corneal degeneration in 129 mice. Toxicol Pathol 2007;35:819-26.
  95. Pettenati MJ, Sweatt AJ, Lantz P, et al. The human cornea has a high incidence of acquired chromosome abnormalities. Hum Genet 1997;101:26-29.
  96. Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease—a review. Clin Experiment Ophthalmol 2010;38:141-53.
  97. Spoerl E, Raiskup-Wolf F, Kuhlisch E, Pillunat LE. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008;24:S737-40.
  98. Rabinowitz YS, Nesburn AB, McDonnell PJ. Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology 1993;100:181-86.
  99. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529-54.
  100. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol 1992;76:590-91.
  101. Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, Ahmad N, Macdonald J, Evert N, Bingham A, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017 Jan 3;317(1):59-68.
  102. Chervenak FA, Jeanty P, Cantraine F, Chitkara U, Venus I, Berkowitz RL, Hobbins JC. The diagnosis of fetal microcephaly. Am J Obstet Gynecol 1984 Jul 1;149(5):512-517.
  103. Papageorghiou AT, Thilaganathan B, Bilardo CM, Ngu A, Malinger G, Herrera M, Salomon LJ, Riley LE, Copel JA. ISUOG Interim Guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals. Ultrasound Obstet Gynecol 2016 Apr;47(4):530-532.
  104. Chibueze EC, Parsons AJ, Lopes KD, Yo T, Swa T, Nagata C, Horita N, Morisaki N, Balogun OO, Dagvadorj A, et al. Diagnostic accuracy of ultrasound scanning for prenatal microcephaly in the context of Zika virus infection: a systematic review and meta-analysis. Sci Rep 2017 May 23;7(1):2310.
  105. Cordeiro MT. Zika virus: laboratory diagnosis. In: Zika in focus. Springer International Publishing; 2017. pp. 59-62.
  106. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, et al. Zika virus associated with microcephaly. N Engl J Med 2016 Mar 10;374(10):951-958.
  107. Zare Mehrjardi M, Keshavarz E, Poretti A, Hazin AN. Neuroimaging findings of Zika virus infection: a review article. Jpn J Radiol 2016 Dec;34(12):765-770.
  108. Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016 Jan;47(1):6-7.
  109. Araujo AQ, Silva MT, Araujo AP. Zika virus-associated neurological disorders: a review. Brain 2016;139(8):2122-2130.
  110. Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016 Dec 15;375(24):2321-2334.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.